A novel subtype of primary prostatic adenocarcinoma: A case report

Yang,Xiaoqing; Xu,Chen; Guo,Jianing; Yang,Chunrui; Yang,Yuming; Han,Ruifa

doi:10.3892/ol.2013.1557

A novel subtype of primary prostatic adenocarcinoma: A case report

Authors:
- Xiaoqing Yang
- Chen Xu
- Jianing Guo
- Chunrui Yang
- Yuming Yang
- Ruifa Han
View Affiliations

Affiliations: Tianjin Institute of Urology, Department of Urology, Second Hospital of Tianjin Medical University, Hexi, Tianjin, P.R. China, Department of Colorectal Surgery, Affiliated Hospital of Nankai University, Hongqiao, Tianjin, P.R. China
Published online on: September 2, 2013 https://doi.org/10.3892/ol.2013.1557
Pages: 1303-1306

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The present study reports the novel case of an 81‑year‑old male with prostatic adenocarcinoma (PAC), whose histopathological study revealed a pure urothelial carcinoma (UC) that originated, however, from the prostatic glandular epithelium. The levels of serum prostate‑specific antigen (PSA) were extraordinarily high in this patient. An MRI scan indicated a prostatic neoplasm and no malignant changes were observed in the bladder or other areas of the urinary tract. Hematoxylin and eosin‑stained sections revealed a diagnosis of pure UC with no other form of differentiation (typical adenocarcinoma or squamous differentiation). The immunohistochemical findings were positive for PSA and P504S, and negative for CK7, CK20, 34βE12 and p63. A diagnosis of primary PAC (solid carcinoma) originating from the prostate was made based on the clinical, histopathological and immunohistochemical observations. This case was susceptible to diagnostic errors, however, a novel subtype of primary PAC was identified and termed the UC‑like subtype.

View Figures

View References

1	Kunju LP, Mehra R, Snyder M and Shah RB: Prostate-specific antigen, high-molecular-weight cytokeratin (clone 34betaE12), and/or p63: an optimal immunohistochemical panel to distinguish poorly differentiated prostate adenocarcinoma from urothelial carcinoma. Am J Clin Pathol. 125:675–681. 2006. View Article : Google Scholar
2	Varma M, Morgan M, Amin MB, et al: High molecular weight cytokeratin antibody (clone 34betaE12): a sensitive marker for differentiation of high-grade invasive urothelial carcinoma from prostate cancer. Histopathology. 42:167–172. 2003. View Article : Google Scholar
3	Epstein JI: PSA and PAP as immunohistochemical markers in prostate cancer. Urol Clin North Am. 20:757–770. 1993.PubMed/NCBI
4	Shah RB, Zhou M, LeBlanc M, Snyder M and Rubin MA: Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer. Am J Surg Pathol. 26:1161–1168. 2002. View Article : Google Scholar : PubMed/NCBI
5	Ud Din N, Qureshi A and Mansoor S: Utility of p63 immunohistochemical stain in differentiating urothelial carcinomas from adenocarcinomas of prostate. Indian J Pathol Microbiol. 54:59–62. 2011.PubMed/NCBI
6	Hashimoto H, Watanabe Y, Mizunaga M, et al: A case of primary transitional cell carcinoma of the prostate. Hinyokika Kiyo. 35:1235–1238. 1989.(In Japanese).
7	Mottola A, Di Cello V, Lunghi F, et al: Diagnostic, clinical and therapeutic aspects of primary transitional cell carcinoma of the prostate. Minerva Urol Nefrol. 43:37–39. 1991.(In Italian).
8	Mai KT, Collins JP and Veinot JP: Prostatic adenocarcinoma with urothelial (transitional cell) carcinoma features. Appl Immunohistochem Mol Morphol. 10:231–236. 2002. View Article : Google Scholar : PubMed/NCBI
9	Morikawa H, Cho M, Takada S, et al: A case of primary transitional cell carcinoma of the prostate. Hinyokika Kiyo. 49:357–360. 2003.(In Japanese).
10	Ushida H, Koizumi S and Okada Y: A prostatic duct carcinoma difficult to distinguish from transitional cell carcinoma: a case report. Hinyokika Kiyo. 50:535–538. 2004.(In Japanese).
11	Huang Q, Chu PG, Lau SK and Weiss LM: Urothelial carcinoma of the urinary bladder with a component of acinar/tubular type differentiation simulating prostatic adenocarcinoma. Hum Pathol. 35:769–773. 2004. View Article : Google Scholar
12	Curtis MW, Evans AJ and Srigley JR: Mucin-producing urothelial-type adenocarcinoma of prostate: report of two cases of a rare and diagnostically challenging entity. Mod Pathol. 18:585–590. 2005. View Article : Google Scholar : PubMed/NCBI
13	Martínez-Rodríguez M, Ramos D, et al: Poorly differentiated adenocarcinomas of prostate versus high-grade urothelial carcinoma of the bladder: a diagnostic dilemma with immunohistochemical evaluation of 2 cases. Int J Surg Pathol. 15:213–218. 2007.
14	Kumaresan K, Kakkar N, Verma A, et al: Diagnostic utility of α-methylacyl CoA racemase (P504S) & HMWCK in morphologically difficult prostate cancer. Diagn Pathol. 5:832010.
15	Bassily NH, Vallorosi CJ, Akdas G, Montie JE and Rubin MA: Coordinate expression of cytokeratins 7 and 20 in prostate adenocarcinoma and bladder urothelial carcinoma. Am J Clin Pathol. 113:383–388. 2000. View Article : Google Scholar : PubMed/NCBI